In early January of 2024, the biotechnology research company Qvinâ„¢ made history; the FDA clearance of its Q-Padâ„¢ and A1c Test marked the first FDA approval for menstrual blood health testing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results